The Basic Study of Multidisciplinary Treatment for Malignant Tumors using MnSOD Gene Therapy
MnSOD基因治疗多学科综合治疗恶性肿瘤的基础研究
基本信息
- 批准号:10470196
- 负责人:
- 金额:$ 2.56万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1) We confirmed that MnSOD gene overexpression increased the in vivo effects of radiotherapy, hyperthermia, and chemotherapy, using MnSOD gene-tranfected fibrosarcoma cell line, FSa-II.2) Experiments using scid mice revealed that overexpression of MnSOD gene suppressed spontaneous apoptosis without a resultant alteration in in vivo growth of the mouse fibrosarcoma, FSa-II.3) Newly developed microscopic system was available to indicate that MnSOD gene overexpression increased apoptosis after hyperthermic treatments.4) In vitro timelapse microscopic observation of cellular moving ability did not show any difference by MnSOD gene overexpression.5) Intracellular MnSOD activity following gene-transfection by in vivo electroporation increased as concentration of DNA increased from 5 to 5Oμg/6μl, and reached peak at third day after transfection.6) MnSOD gene-transfection by in vivo electroporation increased the in vivo effects of radiotherapy and hyperthermia. MnSOD gene was transfected by in vivo electroporation for FSa-II tumor in C3H/He mice. Tumors were irradiated at graded doses or heated at 44℃ for 60 min at third day after gene-transfection. The effects of treatments were analyzed by tumor growth-50 method and tumor control dose-50 method.This study indicated that MnSOD overexpression increased thermosensitivity of cells in vitro, and substantially reduces the tumorigenicity, resulting in a significant increase in tumor growth time in vivo. Reduced tumorigenicity by MnSOD overexpression also resulted in a significant increase in tumor control rate by radiotherapy in vivo.
1)我们使用MnSOD基因转染的纤维肉瘤细胞系FSa-II证实MnSOD基因过表达增加了放射治疗、热疗和化学治疗的体内效应。2)使用scid小鼠的实验显示MnSOD基因过表达抑制了小鼠纤维肉瘤的自发凋亡,而不导致体内生长的改变,FSa-II.3)新开发的显微系统可用于表明MnSOD基因过表达增加了热处理后的细胞凋亡。4)在体外时间推移显微镜观察中,MnSOD基因过表达对细胞运动能力没有任何影响。5)在5 ~ 50 μg/6μl的DNA浓度范围内,MnSOD活性随DNA浓度的增加而增加,并在转染后第3天达到峰值。6)MnSOD基因的体内转染增强了放疗和热疗的体内效应。采用电穿孔法将MnSOD基因转染C3 H/He小鼠FSa-II肿瘤。基因转染后第3天,采用不同剂量照射或44℃加热60 min。采用肿瘤生长-50法和肿瘤对照剂量-50法分析治疗效果,结果表明MnSOD过表达增加了体外培养细胞的温度敏感性,并显著降低了致瘤性,导致肿瘤在体内的生长时间显著增加。MnSOD过表达降低致瘤性也导致体内放疗肿瘤控制率显著增加。
项目成果
期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Osamu Honda et al.: "Assessment of Secondary Necrosis of Jurkat Cells Using a New Microscopic System and Double Staining Method with Annexin V and Propidium Iodide"Int J Oncology. 16. 283-288 (2000)
Osamu Honda 等人:“使用新的显微系统和膜联蛋白 V 和碘化丙啶双重染色方法评估 Jurkat 细胞的继发性坏死”Int J Oncology。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masahiro Kuroda et al.: "Overexpression of manganese superoxide dismutase gene suppresses spontaneous apoptosis without a resultant alteration in in vivo growth of the mouse fibrosarcoma. FSa-II"Anticancer Res. 7-10 (2000)
Masahiro Kuroda 等人:“锰超氧化物歧化酶基因的过度表达可抑制自发性细胞凋亡,但不会改变小鼠纤维肉瘤的体内生长。FSa-II”Anticancer Res。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masahiro Kuroda: "A new experimental system for irradiating tumors in mice using a linear accelerator under specific pathogen-free conditions" Acta Med Okayama. 53,2 (in press). (1999)
Masahiro Kuroda:“一种在特定无病原体条件下使用直线加速器照射小鼠肿瘤的新实验系统”Acta Med Okama。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yoshitomo Ando et al.: "The Effect of Calcium on Fas-Mediated Apoptosis and Secondary Necrosis of Jurkat Cells"Int J Mol Med. 7. 243-247 (2000)
Yoshitomo Ando 等:“钙对 Jurkat 细胞 Fas 介导的细胞凋亡和继发性坏死的影响”Int J Mol Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masahiro Kuroda et al.: "Overexpression of manganese superoxide dismutase gene suppresses spontaneous apoptosis without a resultant alteration in vivo growth of the mouse fibrosarcoma, FSa-II"Anticancer Res. (In press). (2000)
Masahiro Kuroda 等人:“锰超氧化物歧化酶基因的过度表达抑制自发性细胞凋亡,而不改变小鼠纤维肉瘤 FSa-II 的体内生长”Anticancer Res。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KURODA Masahiro其他文献
KURODA Masahiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KURODA Masahiro', 18)}}的其他基金
Acceleration of statistical iterative algorithms for graphical models
图模型统计迭代算法的加速
- 批准号:
20500263 - 财政年份:2008
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of New Technique to Concentrate Intra-vascular Injected Gene Vector or Anti-cancer Drugs into Tumor Tissue
血管内注射基因载体或抗癌药物浓缩至肿瘤组织新技术的开发
- 批准号:
14370278 - 财政年份:2002
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The Basic Study for Mn-SOD Gene Therapy
Mn-SOD基因治疗的基础研究
- 批准号:
08044290 - 财政年份:1996
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for international Scientific Research
相似海外基金
Gene Therapy and Radiation Therapy for Prostate Cancer
前列腺癌的基因治疗和放射治疗
- 批准号:
8401887 - 财政年份:2012
- 资助金额:
$ 2.56万 - 项目类别:
Gene Therapy and Radiation Therapy for Prostate Cancer
前列腺癌的基因治疗和放射治疗
- 批准号:
8239143 - 财政年份:2012
- 资助金额:
$ 2.56万 - 项目类别:
Gene Therapy and Radiation Therapy for Prostate Cancer
前列腺癌的基因治疗和放射治疗
- 批准号:
8599755 - 财政年份:2012
- 资助金额:
$ 2.56万 - 项目类别:
Gene Therapy and Radiation Therapy for Prostate Cancer
前列腺癌的基因治疗和放射治疗
- 批准号:
8984293 - 财政年份:2012
- 资助金额:
$ 2.56万 - 项目类别:
A fundamental study for particle radiotherapy with concurrent gene therapy using Ad-p53
使用 Ad-p53 进行粒子放射治疗与同步基因治疗的基础研究
- 批准号:
22791198 - 财政年份:2010
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Gene Therapy of Prostate Cancer Using Radioactive Iodine
使用放射性碘治疗前列腺癌
- 批准号:
7729543 - 财政年份:2008
- 资助金额:
$ 2.56万 - 项目类别:
Combined effects of interleukin 12 gene therapy with radiotherapy for mouse model of prostate cancer
白介素12基因治疗联合放疗对前列腺癌小鼠模型的联合作用
- 批准号:
18591771 - 财政年份:2006
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PHASE I-II STUDY ON HSV-TK GENE THERAPY + RADIOTHERAPY FOR PROSTATE CANCER
HSV-TK 基因治疗前列腺癌放射治疗的 I-II 期研究
- 批准号:
7375023 - 财政年份:2005
- 资助金额:
$ 2.56万 - 项目类别:
PHASE I-II STUDY ON HSV-TK GENE THERAPY + RADIOTHERAPY FOR PROSTATE CANCER
HSV-TK 基因治疗前列腺癌放射治疗的 I-II 期研究
- 批准号:
7206801 - 财政年份:2004
- 资助金额:
$ 2.56万 - 项目类别:
Phase I-II Study on HSV-tk Gene Therapy + Radiotherapy for Prostate Cancer
HSV-tk基因治疗前列腺癌放疗的I-II期研究
- 批准号:
7041710 - 财政年份:2003
- 资助金额:
$ 2.56万 - 项目类别: